Outlook Therapeutics, Inc. reports listing or compliance development

Outlook Therapeutics, Inc. filed an 8-K covering a listing or compliance notice. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.